Part A – Drugs and Devices

Drugs and Devices

Pathway

Title 21 > Chapter 9 > Subchapter V > Part A

Details

• Reference: Part A
• Legend: Drugs and Devices
• USCode Year: 2013

Provision Content

U.S. Encyclopedia of Law Coverage

Topic Map

• Title 21/Chapter 9/Subchapter V/Part A/Section 351 – Adulterated Drugs and Devices
• Title 21/Chapter 9/Subchapter V/Part A/Section 352 – Misbranded Drugs and Devices
• Title 21/Chapter 9/Subchapter V/Part A/Section 353 – Exemptions and Consideration For Certain Drugs, Devices, and Biological Products
• Title 21/Chapter 9/Subchapter V/Part A/Section 353a – Pharmacy Compounding
• Title 21/Chapter 9/Subchapter V/Part A/Section 353a-1 – Enhanced Communication
• Title 21/Chapter 9/Subchapter V/Part A/Section 353b – Outsourcing Facilities
• Title 21/Chapter 9/Subchapter V/Part A/Section 353c – Prereview of Television Advertisements
• Title 21/Chapter 9/Subchapter V/Part A/Section 354 – Veterinary Feed Directive Drugs
• Title 21/Chapter 9/Subchapter V/Part A/Section 355 – New Drugs
• Title 21/Chapter 9/Subchapter V/Part A/Section 355-1 – Risk Evaluation and Mitigation Strategies
• Title 21/Chapter 9/Subchapter V/Part A/Section 355a – Pediatric Studies of Drugs
• Title 21/Chapter 9/Subchapter V/Part A/Section 355b – Adverse-Event Reporting
• Title 21/Chapter 9/Subchapter V/Part A/Section 355c – Research Into Pediatric Uses For Drugs and Biological Products
• Title 21/Chapter 9/Subchapter V/Part A/Section 355c-1 – Report
• Title 21/Chapter 9/Subchapter V/Part A/Section 355d – Internal Committee For Review of Pediatric Plans, Assessments, Deferrals, Deferral Extensions, and Waivers
• Title 21/Chapter 9/Subchapter V/Part A/Section 355e – Pharmaceutical Security
• Title 21/Chapter 9/Subchapter V/Part A/Section 355f – Extension of Exclusivity Period For New Qualified Infectious Disease Products
• Title 21/Chapter 9/Subchapter V/Part A/Section 356 – Expedited Approval of Drugs For Serious Or Life-Threatening Diseases Or Conditions
• Title 21/Chapter 9/Subchapter V/Part A/Section 356-1 – Accelerated Approval of Priority Countermeasures
• Title 21/Chapter 9/Subchapter V/Part A/Section 356a – Manufacturing Changes
• Title 21/Chapter 9/Subchapter V/Part A/Section 356b – Reports of Postmarketing Studies
• Title 21/Chapter 9/Subchapter V/Part A/Section 356c – Discontinuance Or Interruption In The Production of Life-Saving Drugs
• Title 21/Chapter 9/Subchapter V/Part A/Section 356c-1 – Annual Reporting On Drug Shortages
• Title 21/Chapter 9/Subchapter V/Part A/Section 356d – Coordination; Task Force and Strategic Plan
• Title 21/Chapter 9/Subchapter V/Part A/Section 356e – Drug Shortage List
• Title 21/Chapter 9/Subchapter V/Part A/Section 356f – Hospital Repackaging of Drugs In Shortage
• Title 21/Chapter 9/Subchapter V/Part A/Section 357 – Repealed. Pub. L. 105-115, Title I, §125(B)(1), Nov. 21, 1997, 111 Stat. 2325
• Title 21/Chapter 9/Subchapter V/Part A/Section 358 – Authority to Designate official Names
• Title 21/Chapter 9/Subchapter V/Part A/Section 359 – Nonapplicability of Subchapter to Cosmetics
• Title 21/Chapter 9/Subchapter V/Part A/Section 360 – Registration of Producers of Drugs Or Devices
• Title 21/Chapter 9/Subchapter V/Part A/Section 360a – Clinical Trial Guidance For Antibiotic Drugs
• Title 21/Chapter 9/Subchapter V/Part A/Section 360a-1 – Clinical Trials
• Title 21/Chapter 9/Subchapter V/Part A/Section 360b – New Animal Drugs
• Title 21/Chapter 9/Subchapter V/Part A/Section 360c – Classification of Devices Intended For Human Use
• Title 21/Chapter 9/Subchapter V/Part A/Section 360c-1 – Reporting
• Title 21/Chapter 9/Subchapter V/Part A/Section 360d – Performance Standards
• Title 21/Chapter 9/Subchapter V/Part A/Section 360e – Premarket Approval
• Title 21/Chapter 9/Subchapter V/Part A/Section 360e-1 – Pediatric Uses of Devices
• Title 21/Chapter 9/Subchapter V/Part A/Section 360f – Banned Devices
• Title 21/Chapter 9/Subchapter V/Part A/Section 360g – Judicial Review
• Title 21/Chapter 9/Subchapter V/Part A/Section 360g-1 – Agency Documentation and Review of Significant Decisions Regarding Devices
• Title 21/Chapter 9/Subchapter V/Part A/Section 360h – Notification and Other Remedies
• Title 21/Chapter 9/Subchapter V/Part A/Section 360h-1 – Program to Improve The Device Recall System
• Title 21/Chapter 9/Subchapter V/Part A/Section 360i – Records and Reports On Devices
• Title 21/Chapter 9/Subchapter V/Part A/Section 360j – General Provisions Respecting Control of Devices Intended For Human Use
• Title 21/Chapter 9/Subchapter V/Part A/Section 360k – State and Local Requirements Respecting Devices
• Title 21/Chapter 9/Subchapter V/Part A/Section 360l – Postmarket Surveillance
• Title 21/Chapter 9/Subchapter V/Part A/Section 360m – Accredited Persons
• Title 21/Chapter 9/Subchapter V/Part A/Section 360n – Priority Review to Encourage Treatments For Tropical Diseases
• Title 21/Chapter 9/Subchapter V/Part A/Section 360n-1 – Priority Review For Qualified Infectious Disease Products